The concentration of circulating DPP-4 is associated with both visceral adipose tissue volume and adipocyte size, and increases concomitantly with the obesity progression, the development of insulin resistance, and the worsening of glucose metabolic abnormalities (26). The gene discussed is DPP4; the disease is obesity disorder.